1. The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma

   • Wenyu Fu
   • Dan Liu
   • Tao Zhao

   Urology - Original Paper 24 November 2022 Pages: 1073 - 1079

2. Analysis of false positive PI-RADS 4 lesions: experience from a single nonacademic center using cognitive fusion

   • Bianca Carla Azevedo de Souza
   • Marco Antonio Soares Novaes
   • Daniel Abensur Athanazio

   Urology - Original Paper 18 February 2023 Pages: 1081 - 1085

3. A prospective evaluation of the effect of finasteride on prostate health index (phi)

   • Peter Ka-Fung Chiu
   • Chun-Hong Chan
   • Chi-Fai Ng

   Urology - Original Paper 01 March 2023 Pages: 1087 - 1092

4. Are hemostatic agents for selective cases of tubeless percutaneous nephrolithotomy necessary for access tract control? A randomized control trial

   • Yong Sun Choi
   • Samuel Ryan Sorkhi
   • Hyuk Jin Cho

   Urology - Original Paper 27 February 2023 Pages: 1093 - 1100

   

5. Predictive value of Controlling Nutritional Status score and Prognostic Nutritional Index for systemic inflammatory response syndrome/sepsis after percutaneous nephrolithotomy

   • Burak Arslan
   • Abdullah Harun Kinik
   • Enver Ozdemir

   Urology - Original Paper 20 March 2023 Pages: 1101 - 1107

   

6. Recent trends in the prescription of opioids in the emergency department in patients with urolithiasis

   • Spencer S. Liem
   • Timothy Demus
   • Jorge F. Pereira

   Urology - Original Paper 13 March 2023 Pages: 1109 - 1116

   

7. Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities

   • Cristina Cano Garcia
   • Mattia Luca Piccinelli
   • Pierre I. Karakiewicz

   Urology - Original Paper 23 February 2023 Pages: 1117 - 1123

   

8. Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation

   • Oscar Selvaggio
   • Marco Finati
   • Giuseppe Carrieri

   Urology - Original Paper Open access 21 February 2023 Pages: 1125 - 1132

   

9. Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation

   • Sanjoy Kumar Sureka
   • Ankit Misra
   • Uday Pratap Singh

   Urology - Original Paper 14 March 2023 Pages: 1133 - 1137

   

10. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease

    • Antonio Benito Porcaro
    • Andrea Panunzio
    • Alessandro Antonelli

    Urology - Original Paper 21 March 2023 Pages: 1139 - 1148

    

11. Female urethroplasty with dorsal onlay buccal mucosal graft: a single institution experience

    • Margaret M. Higgins
    • Derek Wengryn
    • Brian J. Flynn

    Urology - Original Paper Open access 01 March 2023 Pages: 1149 - 1154

    

12. Letter to the editor re: Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction. Chang TL, Chen SF, Kuo HC. Int Urol Nephrol. 2022 Oct;54(10):2511–2519. doi: 10.1007/s11255-022-03285-3. Epub 2022 Jul 11

    • I. M. Pina
    • R. N. Khadr
    • M. S. Floyd Jr

    Urology - Letter to the Editor 12 January 2023 Pages: 1155 - 1156

13. Bladder outlet surgery is effective only in patients with central nervous system disorders and voiding dysfunction proven to be obstructed

    • Hann-Chorng Kuo

    UROLOGY - Letter to the Editor 28 January 2023 Pages: 1157 - 1157

14. Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections

    • S. Nestler
    • C. Peschel
    • A. Neisius

    Correction Open access 25 January 2023 Pages: 1159 - 1159

15. Sarcopenia and cardiovascular disease in patients with and without kidney disease: what do we know?

    • Ozkan Gungor
    • Mustafa Sevinc
    • Ismail Kocyigit

    Nephrology - Review 03 November 2022 Pages: 1161 - 1171

    

16. Frailty, sarcopenia and diabetic kidney disease: where do we stand?

    • Nikolaos D. Karakousis
    • Smaragda Biliou
    • Nikolaos Papanas

    Nephrology - Review 10 November 2022 Pages: 1173 - 1181

    

17. Kidney transplantation: is it a solution to endothelial dysfunction?

    • Mehmet Kanbay
    • Carina Ureche
    • Adrian Covic

    Nephrology - Review 18 November 2022 Pages: 1183 - 1191

    

18. Effect of exercise interventions for sleep quality in patients with chronic kidney disease: a systematic review and meta-analysis

    • Fan Zhang
    • Hui Wang
    • Huachun Zhang

    Nephrology - Review 19 November 2022 Pages: 1193 - 1204

    

19. Cisplatin and AKI: an ongoing battle with new perspectives—a narrative review

    • Simona Volovat
    • Mugurel Apetrii
    • Simona Hogas

    Nephrology - Review 12 December 2022 Pages: 1205 - 1209

    

20. Salt taste threshold and contributory factors of chronic kidney disease patients: a cross-sectional study

    • Ya Wu
    • Fengqin Liao
    • Rong Tang

    Nephrology - Original Paper 01 November 2022 Pages: 1211 - 1218

    

21. Physical function and all-cause mortality in patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis

    • Li Yang
    • Yanwei He
    • Xiaoming Li

    Nephrology - Original Paper 02 November 2022 Pages: 1219 - 1228

    

22. Prognostic value of serum levels of multiple adhesion factors in patients with sepsis-induced acute kidney injury

    • Yan Li
    • Qingsheng Huang
    • Zhiyong Wang

    Nephrology - Original Paper Open access 04 November 2022 Pages: 1229 - 1237

    

23. Effect of total parathyroidectomy in patients with secondary hyperparathyroidism: a retrospective study

    • Xixiang Gong
    • Yi An Wang
    • Yongxin Lu

    Nephrology - Original Paper Open access 04 November 2022 Pages: 1239 - 1245

    

24. Economic evaluation of three dialysis methods in patients with end-stage renal disease in China

    • Zhuang Hong
    • Ye Zhuang
    • Yan Xiong

    Nephrology - Original Paper 14 November 2022 Pages: 1247 - 1254

    

25. Effect of pioglitazone on serum FGF23 levels among patients with diabetic kidney disease: a randomized controlled trial

    • Wutipong Triwatana
    • Bancha Satirapoj
    • Naowanit Nata

    Nephrology - Original Paper 28 November 2022 Pages: 1255 - 1262

    

26. Tripartite motif containing 23 functions as a critical regulator in macrophages to control the pathological feature of diabetic nephropathy

    • Wei Quan
    • Lin Wang

    Nephrology - Original Paper 30 November 2022 Pages: 1263 - 1270

    

27. Cardiac valve calcification as a predictor of cardiovascular outcomes in peritoneal dialysis patients: an inverse probability of treatment weighting analysis

    • Jichao Guan
    • Haiying Xie
    • Shuijuan Shen

    Nephrology - Original Paper 01 December 2022 Pages: 1271 - 1278

    

28. Association between the triglyceride–glucose index and chronic kidney disease in adults

    • Nuozhou Liu
    • Chang Liu
    • Jiaxing Tan

    Nephrology - Original Paper 06 December 2022 Pages: 1279 - 1289

    

29. Economic burden of secondary hyperparathyroidism in Germany: a matched comparison

    • Helmut Reichel
    • Eric Seibert
    • Dominic Meise

    Nephrology - Original Paper Open access 08 December 2022 Pages: 1291 - 1300

    

30. Evaluation of malnutrition and inflammation after total parathyroidectomy in patients on maintenance dialysis

    • Xiaochun Zhou
    • Yuke Kong
    • Jianqin Wang

    Nephrology - Original Paper 12 December 2022 Pages: 1301 - 1309

    

31. Utility of a modified Controlling Nutritional Status score in mortality risk assessment of patients on hemodialysis

    • Nobuhisa Morimoto
    • Kevin Y. Urayama
    • Hiroyuki Tanaka

    Nephrology - Original Paper 16 December 2022 Pages: 1311 - 1320

    

32. To evaluate the relationship between serum magnesium and parathyroid hormone levels in peritoneal dialysis and hemodialysis patients

    • Najmeh Shamspour
    • Malihe Molahoseini
    • Amir Baniasad

    Nephrology - Original Paper 16 December 2022 Pages: 1321 - 1327

    

33. Serum irisin level is higher in peritoneal dialysis than in hemodialysis

    • Xin-Yu Song
    • Si-Jia Zhou
    • Ai-Hua Zhang

    Nephrology - Original Paper 17 December 2022 Pages: 1329 - 1334

34. Comparison of soluble suppression of tumorigenicity 2 and brachial hemodynamic parameters between dialysis modalities in patients with end-stage kidney disease

    • Hacı hasan Yeter
    • Ceren Karacalik
    • Ulver Derici

    Nephrology - Original Paper 18 December 2022 Pages: 1335 - 1342

    

35. Effects of febuxostat on delaying chronic kidney disease progression: a randomized trial in China

    • Hongtao Yang
    • Rong Li
    • Wenxiu Chang

    Nephrology - Original Paper 19 December 2022 Pages: 1343 - 1352

    

36. Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3–5 chronic kidney disease

    • Yue Hu
    • Xiaotong Wang
    • Defeng Pan

    Nephrology - Original Paper Open access 23 December 2022 Pages: 1353 - 1363

    

37. Exercise intolerance and malnutrition associated with all-cause mortality in elderly patients undergoing peritoneal dialysis: a single-center prospective cohort study

    • Hiroki Yabe
    • Keiko Okada
    • Yasuhiko Ito

    Nephrology - Original Paper 23 December 2022 Pages: 1365 - 1372

    

38. Effect of finerenone on cardiovascular events in kidney disease and/or diabetes: a meta analysis of randomized control trials

    • Yuhan Zhu
    • Maifen Song
    • Yanyan Liu

    Nephrology - Original Paper 26 December 2022 Pages: 1373 - 1381

    

39. Urinary tract endometriosis masquerading as a renal mass in hepatocyte nuclear factor-1 beta gene mutation

    • Tung Lin Lee
    • Henry Sun Sien Ho
    • Cynthia Ciwei Lim

    Nephrology - Letter to the Editor 12 November 2022 Pages: 1383 - 1384

    

40. Paricalcitol in the treatment of MHD with secondary hyperparathyroidism and bone pain

    • Jingyi Chen
    • Liang Cai
    • Santao Ou

    Nephrology - Letter to the Editor 29 November 2022 Pages: 1385 - 1388

    

41. Non-typical anti-GBM disease with intraglomerular granulomatous reaction and anti-PLA2R-negative membranous nephropathy in the context of IgM/κ paraproteinemia

    • WenTing Zhao
    • Jing Li
    • Tao Wang

    Nephrology - Letter to the Editor 01 December 2022 Pages: 1389 - 1391

    

42. Extremely high prevalence of decreased GFR in the oldest elderly nursing home residents

    • Ivana Juric
    • Petar Kes
    • Nikolina Basic-Jukic

    Nephrology - Letter to the Editor 15 December 2022 Pages: 1393 - 1394